Life sciences companies are faced with one of the most common, yet difficult challenges in business: Costs are rising while margins are shrinking. As drug patents expire, competition from generic manufacturers grows. Research and development costs are rising, while complying with drug regulations and safety protocols is becoming more complicated and costly. BearingPoint’s team of consultants can help you meet these and other challenges by collaborating with you to deliver tailored solutions that support your business objectives.
In spite of these challenges, we see a number of factors driving growth opportunities within the life sciences industry. Globalization, technology advances, robust product pipelines, and consolidation of products, personnel and brain power all generate the potential for growth. And the reality of an aging population will create even greater demand for prescription medication for quite some time.
At BearingPoint, we have insight into the ever-changing regulatory environment and the ability to support your needs from strategy through execution. We listen to you, collaborate with you and work with leading industry partners, in conjunction with our own company-wide resources, to help you solve your most important challenges.
We use an account-centric model and our Life Sciences industry experience to bring actionable thought leadership to the table. We can help you create new sales models, transform operations, innovate to speed new product development and anticipate regulatory changes.
BearingPoint serves all of the top 10 Forbes Global drug and biotech companies,* as well leading medical device companies and medical distributors.
* Statistic based on clients for which BearingPoint performed services between January 2005 – March 2006; top 10, 20 and 25 companies are as published by Forbes in its 2006 Forbes Global 2000 list.
How can we help your organization transform? Contact Us
